BELE INVEST ApS: Financial statements 2015
CVR: 20275499
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
BELE INVEST ApS (CVR 20275499) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 4,781 and a net result of DKK -163,046 compared with DKK -1,579,251 the year before. Equity in the 2015 report amounted to DKK 59,854. The solvency ratio was 2.1%.
- Gross Profit
- DKK 4,781
- Profit/Loss
- DKK -163,046
- Equity
- DKK 59,854
- Total Assets
- DKK 2,809,370
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 5K | -163K | 60K | - |
| 2014 | - | -1.4M | -1.6M | 223K | - |
| 2013 | - | -1.2M | -1M | -848K | - |
Official annual report
How creditworthy is BELE INVEST ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 19, 2015, Harry Rosenberg is registered as director of BELE INVEST ApS.
As of November 14, 2015, Jørgen Christian Rasmussen has stepped down as adm. dir. of BELE INVEST ApS.
BELE INVEST ApS has published its annual report for 2014. Gross profit came to DKK -1,386,561, and the net result was DKK -1,579,251.
As of April 29, 2015, Jørgen Christian Rasmussen is registered as adm. dir. of BELE INVEST ApS.
As of April 29, 2015, Bo Lauritzen has stepped down as liquidator of BELE INVEST ApS.
On April 29, 2015, BELE INVEST ApS exited liquidation.
As of February 20, 2015, Bo Lauritzen is registered as liquidator of BELE INVEST ApS.
As of February 20, 2015, Jørgen Christian Rasmussen has stepped down as direktion of BELE INVEST ApS.
On February 20, 2015, BELE INVEST ApS entered liquidation.
About BELE INVEST ApS
BELE INVEST ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 1997. The company has been dissolved on 26 July 2017. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named T-CELLIC A/S and TORSANA ONCOLOGY SYSTEMS A/S. The company has 15 employees (2005). In 2015, the company reported a gross profit of DKK 4,781 and a net result of DKK -163,046 compared with DKK -1,579,251 the year before. Equity in the 2015 report amounted to DKK 59,854.